[tpaschalis]

Isn't it possible that less regulation can help propel research, for "good" goals? I think that in 2018, novel medical applications would be far more profitable than a biological weapons, and in the end of the day, that's what matters to companies.

For example, I'm not sure that in USA it would be possible for a terminally ill patient can opt-in to a dangerous/risky/experimental new form of treatment, while it could save thousands of others if successful.

[sampo]

Even if the patient themselves agrees to the experimental treatment, but then dies, maybe even in a gruesome manner, is it still possible for the patient's family to sue the biotech startup for large sums of money?